Neuromuscular monitoring

Current Opinion in Anaesthesiology

Volumn 14, Issue 6, 2001, Pages 655-659

  Viby Mogensen, J ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CURARE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; VECURONIUM;

ACCELERATION; ACOUSTICS; ANESTHESIA; DIAPHRAGM; ELECTROMYOGRAPHY; FACE MUSCLE; HAND MUSCLE; HUMAN; LARYNX MUSCLE; MAJOR CLINICAL STUDY; MUSCLE CONTRACTION; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; THUMB;

EID: 0035203423     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200112000-00010     Document Type: Review

References (32)

1. Postoperative residual curarization and evidence-based anaesthesia
2. Perioperative monitoring of neuromuscular transmission using acceleromyography prevents residual neuromuscular block following pancuronium
3. Postoperative muscle paralysis after rocuronium: Less residual block when acceleromyography is used
4. Measurement of acceleration: A new method of monitoring neuromuscular function
5. TOF-tube
6. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles
7. The orbicularis oculi and the adductor pollicis muscles as monitors of atracurium block of laryngeal muscles
8. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans
9. The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles
10. Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles
11. Intramuscular versus surface electromyography of the diaphragm for determining neuromuscular blockade
12. Neuromuscular monitoring at the orbicularis oculi may overestimate the blockade in myasthenic patients
13. Use of disposable electrode for recurrent laryngeal nerve monitoring
14. A new method of monitoring the effect of muscle relaxants on laryngeal muscle using surface laryngeal electromyography
15. Comparison of succinylcholine with two doses of rocuronium using a new method of monitoring neuromuscular block at the laryngeal muscles by surface laryngeal electromyography
16. Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans
17. The lumbar paravertebral region provides a novel site to assess neuromuscular block at the diaphragm
18. The relation of phonomyography to force production in the evaluation of muscle relaxants
19. Acoustic monitoring of intraoperative neuromuscular block
20. Temporal relation between acoustic and force responses at the adductor pollicis during nondepolarizing neuromuscular block
21. Post tetanic count (PTC): A new method of evaluating an intense non-depolarizing neuromuscular blockade
22. Relationship of post tetanic count and train-of-four response during intense neuromuscular blockade caused by atracurium
23. Evaluation of intense neuromuscular blockade caused by vecuronium using post tetanic count (PTC)
24. Onset and duration of action of rocuronium: From tracheal, through intense block to complete recovery
25. Residual curarization in the recovery room
26. Residual curarisation: A comparative study of atracurium and pancuronium
27. Postoperative neuromuscular blockade: A comparison between atracurium, vecuronium, and pancuronium
28. Attenuated ventilatory response to hypoxaemia at vecuronium-induced partial neuromuscular block
29. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans
30. Residual neuromuscular block is a risk factor for postoperative pulmonary complications: A prospective, randomised and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium
31. Residual curarization in the recovery room after vecuronium
32. Postoperative residual block after intermediate-acting neuromuscular blocking drugs